Copyright: Immunotech Applied Science Limited   京ICP备19008112号-1    

Company News
Industry News
THE PARTY BRANCH OF IMMUNOTECH BIOPHARA LTD-B (06978. HK) WAS AWARDED THE HONOR OF FOUR-STAR PARTY ORGANIZATION IN THE ECONOMIC DEVELOPMENT ZONE
GOOD NEWS | YONGTAI RUIKE HAS SUCCESSFULLY OBTAINED THE NATIONAL "HIGH-TECH ENTERPRISE" CERTIFICATION!
Immunotech Biophara Ltd-B (06978. HK) and Corning Incorporated Jointly Expanding Product Commercialization Cooperation
HEAVYWEIGHT AWARD | IMMUNOTECH BIOPHARA LTD-B (06978. HK) WAS AWARDED THE "OUTSTANDING INNOVATION ENTERPRISE" IN BEIJING ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE IN 2023
Clinical Progress | Immunotech Biophara Ltd-B (06978. HK) aT19 Injection Successfully received an approval of Clinical Trial
Good News | Zhang Yonghua, Director of NGMC Product Department at Immunotech Biophara Ltd-B (06978. HK) , elected as "2023 Yizhuang Role Model"
FOUR ENTERPRISES HAVE BEEN AWARDED NATIONAL LEVEL DEMONSTRATION AWARDS IN BDA
A GOOD START! IMMUNOTECH BIOPHARA LTD (06978.HK) WAS SUCCESSFULLY SELECTED AS ONE OF THE 2023 KEY PRODUCT, PROCESS "ONE-STOP" APPLICATION DEMONSTRATION DIRECTIONS AND PROMOTION INSTITUTIONS
THE FIRST NATIONAL CONFERENCE OF INVESTIGATOR FOR THE PHASE II CLINICAL TRIAL OF IMMUNOTECH BIOPHARA LTD-B (06978.HK)  CAR-T-19 INJECTION WAS SUCCESSFULLY HELD
HEAVYWEIGHT AWARD | IMMUNOTECH BIOPHARA LTD-B(06978.HK) WON THE "GOLD AWARD"FOR THE TOP 10 INDUSTRIAL ENTERPRISES IN THE PHARMACEUTICAL SUPPIY CHAIN
Page up
1
2
...
5